Gonzalo Patricio Labarca Trucios, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 32 | 2023 | 1875 | 7.450 |
Why?
|
| Continuous Positive Airway Pressure | 13 | 2022 | 575 | 3.360 |
Why?
|
| Bronchoscopy | 23 | 2022 | 909 | 2.160 |
Why?
|
| Sleep Apnea Syndromes | 6 | 2023 | 975 | 1.700 |
Why?
|
| Pulmonary Emphysema | 7 | 2021 | 684 | 1.380 |
Why?
|
| Polysomnography | 9 | 2023 | 1848 | 1.300 |
Why?
|
| Pneumonectomy | 9 | 2021 | 1119 | 0.970 |
Why?
|
| Cardiovascular Diseases | 9 | 2023 | 15502 | 0.910 |
Why?
|
| Chile | 10 | 2021 | 256 | 0.890 |
Why?
|
| Bronchial Diseases | 4 | 2018 | 150 | 0.880 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 3 | 2017 | 515 | 0.820 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2023 | 3204 | 0.820 |
Why?
|
| Disorders of Excessive Somnolence | 2 | 2022 | 277 | 0.800 |
Why?
|
| Mandibular Advancement | 1 | 2022 | 64 | 0.790 |
Why?
|
| Mediastinum | 4 | 2021 | 266 | 0.760 |
Why?
|
| Lung Neoplasms | 15 | 2022 | 13381 | 0.720 |
Why?
|
| Cluster Analysis | 3 | 2021 | 2707 | 0.670 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2021 | 12149 | 0.660 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2020 | 118 | 0.630 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 1380 | 0.530 |
Why?
|
| Severity of Illness Index | 8 | 2020 | 15843 | 0.530 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 7 | 2021 | 5314 | 0.520 |
Why?
|
| Lung | 14 | 2022 | 10002 | 0.510 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2021 | 2422 | 0.500 |
Why?
|
| Neck | 1 | 2019 | 734 | 0.490 |
Why?
|
| Spirometry | 2 | 2017 | 929 | 0.480 |
Why?
|
| Hypereosinophilic Syndrome | 1 | 2015 | 97 | 0.480 |
Why?
|
| Monitoring, Ambulatory | 1 | 2018 | 354 | 0.480 |
Why?
|
| Hypertension | 4 | 2023 | 8540 | 0.480 |
Why?
|
| Humans | 106 | 2023 | 761596 | 0.460 |
Why?
|
| Pyridones | 2 | 2017 | 809 | 0.460 |
Why?
|
| Fasciitis | 1 | 2014 | 67 | 0.450 |
Why?
|
| Bronchi | 5 | 2018 | 845 | 0.440 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 1866 | 0.410 |
Why?
|
| Parathyroidectomy | 1 | 2014 | 242 | 0.410 |
Why?
|
| Pleura | 1 | 2013 | 245 | 0.400 |
Why?
|
| Hypercalcemia | 1 | 2014 | 423 | 0.390 |
Why?
|
| Oxygen | 3 | 2022 | 4227 | 0.380 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 1388 | 0.370 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2022 | 10212 | 0.360 |
Why?
|
| Atherosclerosis | 2 | 2023 | 3407 | 0.360 |
Why?
|
| Prospective Studies | 17 | 2022 | 54423 | 0.360 |
Why?
|
| Mediastinal Neoplasms | 3 | 2019 | 401 | 0.360 |
Why?
|
| Lymphoma | 1 | 2019 | 1901 | 0.350 |
Why?
|
| Pneumothorax | 3 | 2019 | 386 | 0.350 |
Why?
|
| Eosinophilia | 1 | 2014 | 560 | 0.340 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 2273 | 0.340 |
Why?
|
| Leg | 1 | 2014 | 1088 | 0.330 |
Why?
|
| Lung Diseases, Interstitial | 2 | 2018 | 918 | 0.320 |
Why?
|
| Indoles | 1 | 2017 | 1833 | 0.320 |
Why?
|
| Colitis, Ulcerative | 1 | 2021 | 1922 | 0.310 |
Why?
|
| Insulin Resistance | 2 | 2019 | 3964 | 0.310 |
Why?
|
| Emphysema | 2 | 2021 | 238 | 0.300 |
Why?
|
| Respiratory Function Tests | 4 | 2021 | 1682 | 0.290 |
Why?
|
| Radiology | 1 | 2021 | 2113 | 0.280 |
Why?
|
| Oximetry | 2 | 2020 | 459 | 0.280 |
Why?
|
| Tomography, X-Ray Computed | 16 | 2022 | 20568 | 0.280 |
Why?
|
| Surgical Instruments | 2 | 2019 | 383 | 0.280 |
Why?
|
| Male | 46 | 2023 | 360846 | 0.270 |
Why?
|
| Respiratory Tract Diseases | 1 | 2012 | 750 | 0.270 |
Why?
|
| Multiple Pulmonary Nodules | 2 | 2022 | 173 | 0.270 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 5841 | 0.260 |
Why?
|
| Calcinosis | 1 | 2014 | 1469 | 0.260 |
Why?
|
| Middle Aged | 35 | 2023 | 220921 | 0.250 |
Why?
|
| Lymphatic Metastasis | 3 | 2019 | 2915 | 0.240 |
Why?
|
| Renal Dialysis | 1 | 2014 | 1796 | 0.240 |
Why?
|
| Aged | 31 | 2023 | 169310 | 0.240 |
Why?
|
| Endosonography | 3 | 2017 | 609 | 0.230 |
Why?
|
| Female | 39 | 2023 | 392705 | 0.230 |
Why?
|
| Telemedicine | 1 | 2021 | 3052 | 0.230 |
Why?
|
| Bronchial Neoplasms | 2 | 2014 | 110 | 0.210 |
Why?
|
| Trachea | 3 | 2019 | 1089 | 0.210 |
Why?
|
| Sleep | 7 | 2023 | 4768 | 0.210 |
Why?
|
| Sensitivity and Specificity | 7 | 2020 | 14665 | 0.210 |
Why?
|
| Arousal | 3 | 2023 | 1166 | 0.210 |
Why?
|
| Cystic Fibrosis | 1 | 2012 | 1285 | 0.210 |
Why?
|
| Mouth Breathing | 1 | 2022 | 25 | 0.210 |
Why?
|
| Adult | 24 | 2022 | 221210 | 0.210 |
Why?
|
| Biopsy | 8 | 2020 | 6766 | 0.210 |
Why?
|
| Occlusal Splints | 1 | 2022 | 19 | 0.210 |
Why?
|
| Comorbidity | 4 | 2021 | 10508 | 0.200 |
Why?
|
| Reproducibility of Results | 6 | 2021 | 20100 | 0.200 |
Why?
|
| Bronchiectasis | 1 | 2023 | 139 | 0.190 |
Why?
|
| Receptors, CCR8 | 1 | 2021 | 28 | 0.190 |
Why?
|
| Forced Expiratory Volume | 2 | 2019 | 1814 | 0.190 |
Why?
|
| Neoplasm Staging | 6 | 2021 | 11120 | 0.190 |
Why?
|
| Treatment Outcome | 11 | 2022 | 64685 | 0.180 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5672 | 0.180 |
Why?
|
| Obesity, Abdominal | 1 | 2023 | 374 | 0.180 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2021 | 88 | 0.170 |
Why?
|
| Residual Volume | 1 | 2019 | 41 | 0.170 |
Why?
|
| Mouth | 1 | 2022 | 381 | 0.170 |
Why?
|
| Takayasu Arteritis | 1 | 2021 | 105 | 0.170 |
Why?
|
| Quality of Life | 5 | 2022 | 13367 | 0.160 |
Why?
|
| Needles | 2 | 2021 | 451 | 0.160 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2023 | 445 | 0.160 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2022 | 278 | 0.160 |
Why?
|
| Osteoporotic Fractures | 1 | 2023 | 411 | 0.150 |
Why?
|
| Aged, 80 and over | 11 | 2021 | 58984 | 0.150 |
Why?
|
| Wakefulness | 2 | 2023 | 1265 | 0.150 |
Why?
|
| Mining | 1 | 2018 | 93 | 0.150 |
Why?
|
| Cryotherapy | 1 | 2018 | 159 | 0.150 |
Why?
|
| Mediastinal Diseases | 1 | 2018 | 91 | 0.140 |
Why?
|
| Respiratory Aspiration | 1 | 2018 | 89 | 0.140 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 3617 | 0.140 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.140 |
Why?
|
| Vitamin D | 2 | 2021 | 3303 | 0.140 |
Why?
|
| Papilloma | 1 | 2018 | 140 | 0.140 |
Why?
|
| Lung Transplantation | 2 | 2017 | 1310 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2021 | 549 | 0.140 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2019 | 610 | 0.140 |
Why?
|
| Vitamin B 12 | 1 | 2020 | 524 | 0.140 |
Why?
|
| Medical Illustration | 1 | 2017 | 135 | 0.140 |
Why?
|
| Heart Function Tests | 1 | 2017 | 318 | 0.140 |
Why?
|
| Survivors | 3 | 2022 | 2371 | 0.140 |
Why?
|
| Lung Diseases | 2 | 2018 | 1909 | 0.130 |
Why?
|
| Respiratory System | 1 | 2019 | 563 | 0.130 |
Why?
|
| Hospitalization | 3 | 2021 | 10721 | 0.130 |
Why?
|
| Genes, erbB-1 | 1 | 2016 | 162 | 0.130 |
Why?
|
| Mouth Neoplasms | 1 | 2021 | 596 | 0.130 |
Why?
|
| Blood Loss, Surgical | 1 | 2020 | 638 | 0.130 |
Why?
|
| Copper | 1 | 2018 | 369 | 0.130 |
Why?
|
| Th2 Cells | 1 | 2021 | 1060 | 0.130 |
Why?
|
| Models, Anatomic | 1 | 2019 | 683 | 0.130 |
Why?
|
| Marijuana Smoking | 1 | 2019 | 258 | 0.130 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2016 | 78 | 0.130 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2015 | 129 | 0.120 |
Why?
|
| Risk Factors | 8 | 2021 | 74213 | 0.120 |
Why?
|
| Prosthesis Implantation | 1 | 2019 | 592 | 0.120 |
Why?
|
| Panniculitis, Peritoneal | 1 | 2014 | 11 | 0.120 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 39106 | 0.120 |
Why?
|
| Pseudolymphoma | 1 | 2014 | 30 | 0.120 |
Why?
|
| Marijuana Abuse | 1 | 2019 | 411 | 0.120 |
Why?
|
| Placebo Effect | 1 | 2019 | 518 | 0.120 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 575 | 0.120 |
Why?
|
| Airway Obstruction | 1 | 2019 | 661 | 0.120 |
Why?
|
| Blood Glucose | 2 | 2019 | 6391 | 0.120 |
Why?
|
| Chondroma | 1 | 2014 | 53 | 0.120 |
Why?
|
| Thyroiditis | 1 | 2014 | 86 | 0.120 |
Why?
|
| Foreign Bodies | 1 | 2018 | 402 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4576 | 0.110 |
Why?
|
| Absorbable Implants | 1 | 2016 | 338 | 0.110 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2014 | 133 | 0.110 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2014 | 125 | 0.110 |
Why?
|
| Coccidioidomycosis | 1 | 2013 | 37 | 0.110 |
Why?
|
| Standard of Care | 1 | 2017 | 551 | 0.110 |
Why?
|
| Pulmonary Edema | 1 | 2016 | 409 | 0.110 |
Why?
|
| Neoplasms | 2 | 2020 | 22173 | 0.110 |
Why?
|
| Phenotype | 2 | 2021 | 16592 | 0.110 |
Why?
|
| Pleural Effusion | 1 | 2016 | 341 | 0.110 |
Why?
|
| Lung Diseases, Fungal | 1 | 2013 | 126 | 0.110 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1081 | 0.100 |
Why?
|
| Pulmonary Fibrosis | 1 | 2016 | 505 | 0.100 |
Why?
|
| Internal Medicine | 1 | 2020 | 1051 | 0.100 |
Why?
|
| Ultrasonography, Doppler | 1 | 2014 | 462 | 0.100 |
Why?
|
| Prosthesis Failure | 1 | 2018 | 1204 | 0.100 |
Why?
|
| Constriction, Pathologic | 1 | 2016 | 1096 | 0.100 |
Why?
|
| Otolaryngology | 1 | 2019 | 693 | 0.100 |
Why?
|
| Affect | 1 | 2020 | 1486 | 0.100 |
Why?
|
| Plasmacytoma | 1 | 2013 | 171 | 0.100 |
Why?
|
| Coronary Artery Disease | 2 | 2022 | 6403 | 0.100 |
Why?
|
| Ossification, Heterotopic | 1 | 2014 | 235 | 0.100 |
Why?
|
| Axilla | 1 | 2014 | 624 | 0.100 |
Why?
|
| Diagnosis, Differential | 6 | 2020 | 12973 | 0.100 |
Why?
|
| Asthma | 3 | 2023 | 6234 | 0.100 |
Why?
|
| Patient Discharge | 2 | 2022 | 3443 | 0.100 |
Why?
|
| Postoperative Complications | 3 | 2019 | 15633 | 0.100 |
Why?
|
| Ablation Techniques | 1 | 2014 | 248 | 0.100 |
Why?
|
| Respiratory Sounds | 1 | 2016 | 702 | 0.100 |
Why?
|
| Deglutition Disorders | 1 | 2017 | 625 | 0.100 |
Why?
|
| Influenza, Human | 1 | 2023 | 1521 | 0.100 |
Why?
|
| Elasticity | 1 | 2013 | 655 | 0.100 |
Why?
|
| Circadian Rhythm | 2 | 2022 | 2576 | 0.100 |
Why?
|
| Home Care Services | 1 | 2018 | 648 | 0.090 |
Why?
|
| Research Design | 2 | 2017 | 6180 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2021 | 2690 | 0.090 |
Why?
|
| Disease Progression | 3 | 2023 | 13510 | 0.090 |
Why?
|
| Stents | 3 | 2019 | 3179 | 0.090 |
Why?
|
| Heart Neoplasms | 1 | 2014 | 362 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 1886 | 0.090 |
Why?
|
| Vital Capacity | 1 | 2013 | 971 | 0.090 |
Why?
|
| Pandemics | 2 | 2021 | 8656 | 0.090 |
Why?
|
| Antirheumatic Agents | 1 | 2020 | 1373 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2019 | 22176 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 26129 | 0.090 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 1010 | 0.090 |
Why?
|
| Occupational Diseases | 1 | 2018 | 1490 | 0.090 |
Why?
|
| Hospitals | 2 | 2022 | 3883 | 0.090 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 15266 | 0.080 |
Why?
|
| Achilles Tendon | 1 | 2012 | 180 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 6484 | 0.080 |
Why?
|
| Cause of Death | 1 | 2020 | 3683 | 0.080 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2012 | 450 | 0.080 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 1626 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2022 | 8633 | 0.080 |
Why?
|
| Critical Illness | 1 | 2022 | 2723 | 0.080 |
Why?
|
| Tendon Injuries | 1 | 2012 | 328 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3878 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 2169 | 0.070 |
Why?
|
| Dyspnea | 1 | 2016 | 1347 | 0.070 |
Why?
|
| Carcinoma | 1 | 2019 | 2330 | 0.070 |
Why?
|
| Endoscopy | 1 | 2018 | 1851 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 3080 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2016 | 2425 | 0.070 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 6345 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2019 | 9319 | 0.070 |
Why?
|
| Fibrosis | 1 | 2013 | 2049 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 12059 | 0.070 |
Why?
|
| Papillomavirus Infections | 1 | 2018 | 1613 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 2022 | 80647 | 0.060 |
Why?
|
| Prevalence | 2 | 2021 | 15733 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 12463 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2021 | 8481 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8554 | 0.060 |
Why?
|
| Echocardiography | 1 | 2017 | 4989 | 0.060 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2020 | 3763 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 4514 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2023 | 41495 | 0.060 |
Why?
|
| Pharyngeal Muscles | 1 | 2023 | 81 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2023 | 23996 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2016 | 5971 | 0.050 |
Why?
|
| Incidence | 1 | 2021 | 21355 | 0.050 |
Why?
|
| Mandelic Acids | 1 | 2022 | 46 | 0.050 |
Why?
|
| Cognition | 1 | 2020 | 6992 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2020 | 12953 | 0.050 |
Why?
|
| Young Adult | 3 | 2021 | 59260 | 0.050 |
Why?
|
| Prostheses and Implants | 2 | 2019 | 1271 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2017 | 7968 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 5127 | 0.050 |
Why?
|
| Receptors, Phospholipase A2 | 1 | 2021 | 33 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2021 | 26202 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2019 | 2115 | 0.050 |
Why?
|
| Age Factors | 2 | 2019 | 18399 | 0.040 |
Why?
|
| Tongue | 1 | 2023 | 403 | 0.040 |
Why?
|
| Mutation | 2 | 2016 | 30053 | 0.040 |
Why?
|
| Spain | 1 | 2021 | 487 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 4024 | 0.040 |
Why?
|
| Infant | 1 | 2021 | 36193 | 0.040 |
Why?
|
| Electromagnetic Phenomena | 1 | 2020 | 161 | 0.040 |
Why?
|
| Adolescent | 2 | 2021 | 88326 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2023 | 1596 | 0.040 |
Why?
|
| Bronchoscopes | 1 | 2019 | 64 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2022 | 962 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2021 | 42232 | 0.040 |
Why?
|
| Electromyography | 1 | 2023 | 1394 | 0.040 |
Why?
|
| Eosinophils | 1 | 2023 | 950 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 2022 | 3744 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2021 | 23447 | 0.040 |
Why?
|
| Pigmentation | 1 | 2018 | 144 | 0.040 |
Why?
|
| Snoring | 1 | 2019 | 209 | 0.040 |
Why?
|
| Stroke | 1 | 2020 | 9758 | 0.040 |
Why?
|
| Melanoma | 1 | 2015 | 5709 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 2079 | 0.030 |
Why?
|
| Prednisone | 1 | 2021 | 1563 | 0.030 |
Why?
|
| Thoracostomy | 1 | 2016 | 74 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2020 | 846 | 0.030 |
Why?
|
| Deglutition | 1 | 2017 | 208 | 0.030 |
Why?
|
| Heart Failure | 1 | 2020 | 11671 | 0.030 |
Why?
|
| Benzhydryl Compounds | 1 | 2022 | 916 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2020 | 1835 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2021 | 2220 | 0.030 |
Why?
|
| Aftercare | 1 | 2021 | 914 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2023 | 1881 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2022 | 1333 | 0.030 |
Why?
|
| Child | 1 | 2021 | 80158 | 0.030 |
Why?
|
| Time Factors | 1 | 2014 | 39969 | 0.030 |
Why?
|
| Device Removal | 1 | 2018 | 630 | 0.030 |
Why?
|
| Infection Control | 1 | 2020 | 982 | 0.030 |
Why?
|
| Anesthesia, Local | 1 | 2015 | 277 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 2015 | 429 | 0.030 |
Why?
|
| Tracheostomy | 1 | 2016 | 426 | 0.020 |
Why?
|
| Organ Size | 1 | 2017 | 2254 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 1302 | 0.020 |
Why?
|
| ROC Curve | 1 | 2019 | 3578 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2016 | 1118 | 0.020 |
Why?
|
| Mexico | 1 | 2013 | 764 | 0.020 |
Why?
|
| Medicine | 1 | 2019 | 942 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2012 | 330 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2015 | 947 | 0.020 |
Why?
|
| Cough | 1 | 2014 | 594 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 2630 | 0.020 |
Why?
|
| Rupture | 1 | 2012 | 443 | 0.020 |
Why?
|
| Syndrome | 1 | 2016 | 3267 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2016 | 1892 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3465 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 1626 | 0.020 |
Why?
|
| Community-Acquired Infections | 1 | 2013 | 469 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2012 | 532 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2014 | 697 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2014 | 622 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2013 | 753 | 0.020 |
Why?
|
| Smoking | 2 | 2015 | 9053 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 1496 | 0.020 |
Why?
|
| Travel | 1 | 2013 | 796 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2013 | 2643 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2012 | 769 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3639 | 0.020 |
Why?
|
| Patient Selection | 1 | 2019 | 4244 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3600 | 0.020 |
Why?
|
| Cattle | 1 | 2012 | 3849 | 0.020 |
Why?
|
| Reoperation | 1 | 2016 | 4303 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 3889 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2023 | 7859 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11076 | 0.020 |
Why?
|
| Acute Disease | 1 | 2016 | 7237 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 6965 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9280 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 4062 | 0.010 |
Why?
|
| Pneumonia | 1 | 2013 | 2143 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 6484 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 18255 | 0.010 |
Why?
|
| Animals | 1 | 2012 | 168475 | 0.000 |
Why?
|